Amanta Healthcare Ltd

Amanta Healthcare Ltd

Amanta Healthcare Ltd has issued a notice to shareholders regarding the 31st Annual General Meeting (AGM) and Integrated Annual Report for the Financial Year 2025-26. The meeting will be held on September 16, 2026, through video conferencing. The company has also provided a web-link for accessing the Annual Report, as per Regulation 36(1)(b) of the SEBI Listing Regulations, 2015.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has announced the dispatch of its Annual Report for F.Y. 2025-26 and e-voting information for the 31st Annual General Meeting, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has announced its Annual Report for Financial Year 2025-26, with the 31st Annual General Meeting scheduled for September 16, 2026, through video conferencing.

Amanta Healthcare Ltd

Amanta Healthcare Ltd announced its 31st Annual General Meeting and Annual Report for F.Y. 2025-26, to be held on September 16, 2026, through Video Conferencing (VC) / Other Audio-Visual means (OAVM). The meeting will consider the business as set out in the Notice, pursuant to the relevant circulars issued by the Ministry of Corporate Affairs and under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Amanta Healthcare Ltd

Amanta Healthcare Ltd announced its Annual Report for Financial Year 2025-26, along with the Notice convening its 31st AGM, to be held on September 16, 2026. The report and notice are available on the company's website and have been dispatched electronically to shareholders.

Amanta Healthcare Ltd

Amanta Healthcare Ltd submitted newspaper clippings for an advertisement addressed to shareholders for the Annual General Meeting, in compliance with SEBI regulations.

Amanta Healthcare Ltd

Amanta Healthcare Ltd reported Q1 FY27 earnings with revenue of INR69 crores, up 5% YoY, and EBITDA margin of 22%. The company is expanding its SteriPort capacity and strengthening its small volume SVP portfolio. A 10.8 MW captive solar power project has been commissioned, expected to reduce power cost and improve operating margins.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI regulations, detailing the utilization of the fund raised through its public issue.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has published its financial results for the quarter ended June 30, 2026, in newspapers, as per Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has submitted the audio recording of its post-results conference call held on August 6, 2026, which can be accessed on the company's website.

Amanta Healthcare Ltd

Amanta Healthcare Ltd announced Q1FY27 results with revenue of ₹68.8 crore, a 5.4% YoY growth, driven by improved product mix and better price realizations. EBITDA stood at ₹15.2 crore with a 200 bps decline in margins to 22% due to higher raw material, employee cost and other operating costs. PAT stood at ₹3.3 crore, impacted by higher finance costs.

Amanta Healthcare Ltd

Amanta Healthcare Ltd submitted a statement of deviation or variation in utilization of funds raised through IPO for the quarter ended June 30, 2026, as per Regulation 32 of the SEBI Listing Regulations. The company confirmed that there has been no deviation or variation in the use of proceeds of funds raised.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has released its Q1FY27 Investor Presentation, detailing its financial results for the quarter ended June 30, 2026. The presentation highlights the company's revenue growth, production metrics, and financial performance.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has approved unaudited financial results for the quarter ended June 30, 2026, and other matters at its Board meeting on August 5, 2026.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has announced the outcome of its board meeting to approve unaudited financial results for the quarter ended 30th June 2026.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has announced the inclusion of Mr. Nilesh Punjabi as Senior Management Personnel (SMP) of the Company, as recommended by the Nomination and Remuneration Committee.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has announced the schedule of its earnings conference call for Q1 ended June 30, 2026, to be held on August 6, 2026. The call will discuss the company's financial performance and business updates.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has scheduled a Board Meeting on August 5, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Amanta Healthcare Ltd

Amanta Healthcare Ltd has disclosed an open-market purchase of the company's equity shares by Shri Bhavesh Girishbhai Patel, one of its promoters. This intimation was filed under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, which mandates such disclosures for transactions by promoters and other insiders.